Please login to the form below

Not currently logged in

PharmApprove appoints Solvay's Coos De Graaf

He will to lead the agency's new European office

PharmApprove Coos De GraafRegulatory and scientific communications firm PharmApprove has opened a European office and appointed Coos De Graaf to lead its operations in the region.  

De Graaf, who joins as principal for commercial operations in Europe, has more than 30 years' experience in pharma, including numerous roles in senior management.  

He moves to PharmApprove, a New Jersey, US-headquartered division of Taft and Partners, from Solvay Pharmaceuticals, where he led various functions, including global compliance and clinical and commercial development.  

The opening of a European office signals, said PharmApprove, “a new push towards expanded services and geographic markets”. Under De Graaf's leadership, PharmApprove will continue to support clients preparing to bring new therapeutic agents and devices before assessment agencies.  

"PharmApprove has established client experience in Europe, but adding a leader of Coos De Graaf's calibre positions us extremely well to continue growing to serve our clients globally," said PharmApprove president Laurie Smaldone.   

"In addition we are excited to announce expanded services building upon our success in supporting product approvals to include market access communication support."   

Along with expanding its services, PharmApprove has outlined three key areas of focus: advisory committee preparation, regulatory communication and market access communications support.

24th December 2013

From: Marketing



Featured jobs

Subscribe to our email news alerts


Add my company

WCG is an independent, global agency specialising in healthcare communications. Our value as a company is about being the positive...

Latest intelligence

Waking the sleeping giant
The lights are coming on for healthcare delivery in Africa...
How to get rep buy-in for multi-channel
How do you manage a team who may be resistant to change?...
Blog: Digital therapeutics: within our reach?
Digital therapeutics is a hot topic right now. By using digital technology to manage, treat or even prevent chronic conditions, digital therapeutics is promising to revolutionise healthcare. But is this...